Ignite Creation Date:
2024-05-06 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05304962
Status:
RECRUITING
Last Update Posted:
2023-10-13
First Post:
2022-02-24
Brief Title:
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive HER2-Negative AdvancedMetastatic Breast Cancer
Sponsor:
Regor Pharmaceuticals Inc
Organization:
Regor Pharmaceuticals Inc